Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

A reduced-calorie diet can help pregnant women who develop gestational diabetes avoid the need for insulin injections, ...

The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.